Ardelyx, Inc. (ARDX) vs Avalo Therapeutics, Inc. (AVTX)
Ardelyx, Inc. and Avalo Therapeutics, Inc. are both Biotechnology companies. Ardelyx, Inc. and Avalo Therapeutics, Inc. are of similar size ($859.7M and $843.1M). Ardelyx, Inc. grew revenue faster over the last twelve months: 16.8% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −12.4%) and the lower return on invested capital (−118.2% vs −18.6%). Across the 18 metrics below, Ardelyx, Inc. leads on 9 and Avalo Therapeutics, Inc. on 9.
Valuation
Profitability
| Metric | ARDX | AVTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 64.72% | 65.16% |
| Operating margin | (7.86%) | 0.00% | 0.00% |
| Net margin | (12.35%) | 0.00% | 0.00% |
| Free cash flow margin | (3.97%) | 0.00% | 0.00% |
| Return on equity | (38.61%) | (36.27%) | (57.72%) |
| Return on assets | (10.68%) | (32.50%) | (49.22%) |
| Return on invested capital | (18.62%) | (118.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack